The Journal of Nutritional Biochemistry
Volume 18, Issue 5 , Pages 297-304 , May 2007

Chronic daily administration of ethyl docosahexaenoate protects against gerbil brain ischemic damage through reduction of arachidonic acid liberation and accumulation

Received 21 February 2006 ,Revised 19 April 2006 ,Accepted 8 May 2006.

References 

  1. Banzan NG. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta. 1970;218:1–10
  2. Rehncrona S, Westerberg E, Åkesson B, Siesjö BK. Brain cortical fatty acid and phospholipids during and following complete and severe incomplete ischemia. J Neurochem. 1982;38:84–93
  3. Yoshida S, Ikeda M, Busto R, Santiso M, Martinez E, Ginsberg M. Cerebral phosphoinositide, triacylglycerol and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J Neurochem. 1986;47:744–757
  4. Kubota M, Nakane M, Narita K, Nakagomi T, Tamura A, Hisaki H, et al. Mild hypothermia reduces the rate of metabolism of arachidonic acid following postishemic reperfusion. Brain Res. 1998;779:297–300
  5. Siesjö BK, Katsura K, Zhao Q, Felbergrova S, Pahlmark K, Siesjö P, et al. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma. 1995;12:943–956
  6. Mršić-Pelčić J, Župan G, Maysinger D, Pelčić G, Vitezić D, Simonić A. The influence of MK-801 on the hippocampal free arachidonic acid level and Na+,K+-ATPase activity in global cerebral ischemia-exposed rats. Prog NeuroPsychopharmacol Biol Psychiatry. 2002;26:1319–1326
  7. Zhang JP, Sun GY. Free fatty acids, neutral glycerides, and phosphoglycerides in transient focal cerebral ischemia. J Neurochem. 1995;64:1688–1695
  8. Purdon AD, Rosenberger TA, Shetty HU, Rapoport SI. Energy consumption by phospholipids metabolism in mammalian brain. Neurochem Res. 2002;27:1641–1647
  9. Rao AM, Hatcher JF, Kindy MS, Dempsey RJ. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res. 1999;24:1225–1232
  10. Blanco G, Sanchez G, Mercer RW. Differential regulation of Na, K-ATPase isozymes by protein kinases and arachidonic acid. Arch Biochem Biophys. 1998;359:139–150
  11. Macknight ADC, Leaf A. Regulation of cellular volume. Physiol Rev. 1977;57:510–573
  12. Mrsulja BB, Djuricic BM, Cvejic V, Mrsulja BJ, Abe K, Spatz M, et al. Biochemistry of experimental ischemic brain edema. Adv Neurol. 1980;28:217–230
  13. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 2000;47:8–21
  14. Salem N, Kim HY, Yergey JA. Docosahexaenoic acid: membrane function and metabolism. In:  Simopoulos AP,  Kifer RR,  Martin RE editor. Health effects of polyunsaturated fatty acids in seafoods. Orlando (Fla): Academic Press; 1986;p. 263–317
  15. Glozman S, Green P, Yavin E. Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress. J Neurochem. 1998;70:2484–2491
  16. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Monma Y, et al. Effects of dietary docosahexaenoic acid on survival time and stroke-related behavior in stroke-prone spontaneously hypertensive rats. Gen Pharmacol. 1997;29:401–407
  17. Okada M, Amamoto T, Tomonaga M, Kawachi A, Yazawa K, Mine K, et al. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience. 1996;71:17–25
  18. Krokan HE, Bjerve KS, Mork A. The central bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. Biochim Biophys Acta. 1993;1168:59–67
  19. Cao DH, Zhou C, Sun LP, Xue RH, Xu J, Liu ZL. Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. J Nutr Biochem. 2006;17:234–241
  20. Minamisawa H, Mellergård P, Smith ML, Bengtsson F, Theander S, Möller FB, et al. Preservation of brain temperature during ischemia in rats. Stroke. 1990;21:758–764
  21. Levy DE, Duffy TE. Effect of ischemia on energy metabolism in the gerbil cerebral cortex. J Neurochem. 1975;24:1287–1289
  22. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917
  23. Post RL, Sen AK. Sodium and potassium-stimulated ATPase. Methods Enzymol. 1967;10:762–768
  24. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375–400
  25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
  26. Calapia G, Squadrito F, Rizzo A, Marciano MC, Campo GM, Caputi AP. Multiple actions of the coumarin derivative cloricromene and its protective effects on ischemic brain injury. Naunyn-Schmiedeberg's Arch Pharmacol. 1995;351:209–215
  27. Lai ML, Hsu CY, Liu TH, He YY, Xu J, Navidi M, et al. Effects of fish oil supplementation on acute ischemic brain injury in the rat. Neurology. 1993;43:1227–1232
  28. Patel PM, Drummond JC, Cole DJ, Yaksh TL. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. Brain Res. 1994;650:205–211
  29. Takeuchi Y, Morii H, Tamura M, Hayaishi O, Watanabe Y. A possible mechanism of mitochondrial dysfunction during cerebral ischemia: inhibition of mitochondrial respiration activity by arachidonic acid. Arch Biochem Biophys. 1991;289:33–38
  30. Umemura A, Mabe H, Nagai H, Sugino F. Actions of phospholipases A2 and C on free fatty acid release during complete ischemia in rat neocortex. J Neurosurg. 1992;76:648–651
  31. Sun D, Gilboe DD. Ischemia-induced changes in cerebral mitochondrial free fatty acids, phospholipids and respiration in the rats. J Neurochem. 1994;62:1921–1928
  32. Abe K, Kogure K, Yamamoto H, Imazawa M, Miyamoto K. Mechanism of arachidonic acid liberation during ischemia in gerbil cortex. J Neurochem. 1987;48:503–509
  33. Rapoport SI. In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways. Prostaglandins Other Lipid Mediat. 2005;77:185–196
  34. Pilitsis JG, Diaz FG, O'Regan MH, Phillis JW. Differential effects of phospholipase inhibitors on free fatty acid efflux in rat cerebral cortex during ischemia–reperfusion injury. Brain Res. 2002;951:96–106
  35. Gaetani P, Baena RR, Marzatico F, Lombardi D, Knerich R, Paoletti P. “Ex vivo” release of eicosanoid from human brain tissue: its relevance in the development of brain edema. Neurosurgery. 1991;28:853–857
  36. Ordway RW, Walsh JW, Singer JJ. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science. 1989;244:1176–1179
  37. Zerangue N, Arriza JL, Amar SG, Kavanaugh MP. Differential modulation of human glutamate transporter subtypes by arachidonic acid. J Biol Chem. 1995;270:6433–6435
  38. Chow SC, Jondal M. Polyunsaturated free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T cell through a mechanism independent of phosphoinositide turnover. J Biol Chem. 1990;15:902–907
  39. Bazán NG. Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. Adv Exp Med Biol. 1976;72:317–335
  40. Lee HJ, Ghelardoni S, Chang L, Bosetti F, Rapoport SI, Bazinet RP. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Neurochem Res. 2005;30:677–683
  41. Martin RE. Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res. 1998;54:805–813
  42. Nagafuji T, Koide T, Takato M. Neurochemical correlates of selective neuronal loss following cerebral ischemia: role of decreased Na, K-ATPase. Brain Res. 1992;571:265–271
  43. Lees GJ. Inhibition of sodium–potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brains Res Rev. 1991;16:283–380
  44. Owada S, Larsson O, Arkhammar P, Katz AI, Chibalin AV, Berggren PO, et al. Glucose decreases Na, K-ATPase activity in pancreatic beta-cells: an effect mediated via Ca2+-independent phospholipase A2 and protein kinase C-dependent phosphorylation of the alpha-subunit. J Biol Chem. 1999;274:2000–2008
  45. Karmazyn M, Tuana BS, Dhalla NS. Effect of prostaglandins on rat heart sarcolemmal ATPase. Can J Physiol Pharmacol. 1981;59:1122–1127
  46. Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A. 1983;80:3581–3584
  47. Lowe AG. Functional aspects of active cation transport. In:  Bittar EE editors. Membranes and ion transport. London: Wiley-Interscience; 1971;p. 251–277
  48. Serhan CN. Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther. 2005;105:7–21
  49. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats: 2. Ischemic brain edema. Stroke. 1980;11:593–600
  50. Adachi N, Namba C, Nagaro T, Arai T. Dexamethasone reduces energy utilization in ischemic gerbil brain. Eur J Pharmacol. 2001;427:119–123
  51. Dempsey RJ, Roy MW, Meyer K, Cowen DE, Tai HH. Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg. 1986;64:118–124
  52. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, et al. Novel docosanoids inhibit brain ischemia–reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem. 2003;278:43807–43817
  53. Green P, Glozman S, Weiner L, Yavin E. Enhanced free radical scavenging and decreased lipid peroxidation in the fetal brain after treatment with ethyl docosahexaenoate. Biochim Biophys Acta. 2001;1532:203–212
  54. Cao DH, Xu JF, Xue RH, Zheng WF, Liu ZL. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav. 2004;79:651–659
  55. Wang X, Zhao X, Mao ZY, Liu ZL. Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal culture. Neuroreport. 2003;14:2457–2461

PII: S0955-2863(06)00140-9

doi: 10.1016/j.jnutbio.2006.05.005

The Journal of Nutritional Biochemistry
Volume 18, Issue 5 , Pages 297-304 , May 2007

Article Tools

* Image Usage & Resolution